Minimally invasive techniques require only small incisions, reducing the likelihood of complications and promoting a quicker ...

Necrotizing fasciitis is a rare, life-threatening illness caused by bacteria that aggressively attack the soft tissue of the ...

An international team of researchers led by Professor Dr. Lucas Schirmer and Professor Dr. Julio Saez-Rodriguez from the ...

Ongoing fundamental research on cancer cells could be used to create new drugs and therapies that fight the spread of cancer ...

Microplastics in the air we breathe, our food and water and many of the products around us are polluting our bloodstream and ...

Sickle Cell patients can't accept just any type of blood. It must have specific CEK antigens. Experts have found that 1 in 3 ...

While medical headlines often focus on the biochemical underpinnings of disease, our body's biomechanics are equally crucial.

A simple biomaterial-based strategy that can influence the behavior of cells could pave the way for more effective medical ...

Researchers advance CAR T cell therapy for solid tumors by innovating ways to overcome the unique barriers of solid tumor ...

TriSalus Life Sciences, Inc. ( NASDAQ: TLSI) Q3 2024 Earnings Conference Call November 14, 2024 9:00 AM ET Jim Young - Senior Vice President, Investor Relations & Treasurer Mary Szela - President & ...

The aging and failure of cells that occurs when one part of the body is damaged can spread to other organs, a study suggests.

DiaMedica anticipates top line data for Part 1A in the first half of 2025 which is expected to demonstrate initial proof-of-concept including whether DM199 is safe and lowers blood pressure.